Search results
Venable’s BiologicsHQ Monthly Injection - April 2024 | JD Supra
JD Supra· 6 days agoLatest News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 5 days agoSales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper...
Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson
The Hill via Yahoo Finance· 6 days agoA federal judge on Monday threw out legal challenges to the Medicare negotiation program that had...
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoAbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript April 26, 2024 AbbVie Inc. beats earnings...
Pharma companies soften tone on full IRA impact
Endpoints News· 4 days agoDespite the pharmaceutical industry’s heavy criticism of the Inflation Reduction Act, Johnson & Johnson, Pfizer and Bristol Myers Squibb recently...
May 1, 2024, Letters to the Editor
The Record-Courier· 6 days agoZephyr Cove Resort previously leased from the Forest Service about a half mile of lakefront. Despite public objections, the Forest Service has now agreed...
Judges Hear 1st Challenge to Medicare Drug Price Program to Hit Federal Appeals Court | National Law...
Law.com· 5 days agoA U.S. Court of Appeals for the Fifth Circuit judge seemed skeptical Wednesday of a new Medicare...
PhRMA to Revive Medicare Drug Price Lawsuit Before Fifth Circuit
Bloomberg Law· 7 days agoA health provider trade association, a patient advocacy group, and a top drug lobby will attempt to restore their case against a government drug price-setting program before a federal appeals ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoNew York, USA, May 02, 2024 (GLOBE NEWSWIRE) -- Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli
Investment Opportunities in the Drug Distribution Industry
Morningstar· 6 days agoThe market has rallied behind the US drug distribution industry recently because of the popularity of GLP-1s, easing generic drug deflation, and an increase in specialty asset investments. Drug ...